Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
541
-
542
-
543
-
544
-
545
-
546
-
547
-
548
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity
Published 2019“…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
-
549
-
550
Figure 1 Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates
Published 2014“…<p>Adult wild type animals were exposed to M. nematophilum on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8mg/ml 5-HT caused a 35% decrease in the number of Dar animals following M. nematophilum infection using standard assay conditions (small lawn) (A). …”
-
551
-
552
-
553
-
554
Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice.
Published 2013“…White line indicates the presence of tumor. <b>Panel b:</b> A boxplot of tumor burden in MDA-MB-231 tumor-bearing mice treated with either 13C4 (10 mg/kg) or 1D11(10 mg/kg) for 4 weeks, starting 1 day after tumor cell injection (N = at least 7) showing decrease in tumor burden. …”
-
555
-
556
-
557
-
558
-
559
-
560